Prescribers and patients drive maintenance therapy patterns in a community oncology practice: National guidelines versus the real-world experience

Objective: Previous studies have shown that first-line (1L) maintenance therapy (MT) with poly(ADP-ribose) polymerase inhibitors and/or bevacizumab improves outcomes among patients with advanced ovarian cancer (OC); however, these treatments are underutilized. This study aimed to provide a real-worl...

Description complète

Détails bibliographiques

Auteurs principaux:	Dana M. Chase, Laura Iadeluca, Jonathan Lim, Wan-Yu Tseng, Purva Bulsara, Gregory Patton
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2024-08-01
Collection:	Gynecologic Oncology Reports
Sujets:	Bevacizumab Maintenance therapy Ovarian cancer PARPi Platinum-based chemotherapy
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S235257892400119X
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!